stachydrine has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Guo, S; Guo, W; Liang, Y; Lu, R; Lu, S; Shan, X; Xia, L; Xu, M; Yang, S; Zhang, C; Zhao, P | 1 |
| Cao, TT; Chen, HH; Guo, W; Lu, R; Shan, XL; Tian, J; Wang, SN; Xu, M; Zhang, C; Zhao, P; Zheng, JL | 1 |
2 other study(ies) available for stachydrine and Cardiac Failure
| Article | Year |
|---|---|
A new mechanism of therapeutic effect of stachydrine on heart failure by inhibiting myocardial ferroptosis.
Topics: Animals; Cystine; Ferroptosis; Heart Failure; Iron; Lipid Peroxidation; Mice; Myocytes, Cardiac | 2023 |
Stachydrine hydrochloride alleviates pressure overload-induced heart failure and calcium mishandling on mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Arterial Pressure; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiovascular Agents; Cells, Cultured; Disease Models, Animal; Heart Failure; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Proline; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcomeres; Sarcoplasmic Reticulum; Telmisartan; Ventricular Function, Left | 2020 |